PAX5 alterations in an infant case of KMT2A‐rearranged leukemia with lineage switch
Lineage switch is a rare event at leukemic relapse. While mostly known to occur in KMT2A‐rearranged infant leukemia, the underlying mechanism is yet to be depicted. This case report describes a female infant who achieved remission of KMT2A‐MLLT3‐rearranged acute monocytic leukemia, but 6 months ther...
Saved in:
Published in | Cancer science Vol. 113; no. 7; pp. 2472 - 2476 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.07.2022
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1347-9032 1349-7006 1349-7006 |
DOI | 10.1111/cas.15380 |
Cover
Summary: | Lineage switch is a rare event at leukemic relapse. While mostly known to occur in KMT2A‐rearranged infant leukemia, the underlying mechanism is yet to be depicted. This case report describes a female infant who achieved remission of KMT2A‐MLLT3‐rearranged acute monocytic leukemia, but 6 months thereafter, relapsed as KMT2A‐MLLT3‐rearranged acute lymphocytic leukemia. Whole exome sequencing of the bone marrow obtained pre‐post lineage switch revealed two somatic mutations of PAX5 in the relapse sample. These two PAX5 alterations were suggested to be loss of function, thus to have played the driver role in the lineage switch from acute monocytic leukemia to acute lymphocytic leukemia.
Whole exome sequencing was undertaken on an infant case of KMT2A‐rearranged leukemia that underwent lineage switch from acute monocytic leukemia to acute lymphocytic leukemia. Two somatic mutations in PAX5 consistent with biallelic targeting were identified in the relapse sample, thus suggesting that the subsequent loss of PAX5 function might have played a driver role in the event of lineage switch. |
---|---|
Bibliography: | Funding information Japan Society for the Promotion of Science KAKENHI, Grant/Award Number: JP19J11112, JP17H04224, JP18K19467, JP20H00528, JP21K19405; Project for Cancer Research and Therapeutic Evolution, Grant/Award Number: JP20cm0106509h9905; Practical Research for Innovative Cancer Control, Grant/Award Number: Japan Agency for Medical Research and Development, Grant/Award Number: JP19ck0106468h0001, JP21ck0106531; Princess Takamatsu Cancer Research Fund; The Mother and Child Health Foundation; Japan Leukemia Research Fund. ObjectType-Case Study-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Report-1 ObjectType-Feature-4 content type line 23 ObjectType-Article-3 |
ISSN: | 1347-9032 1349-7006 1349-7006 |
DOI: | 10.1111/cas.15380 |